PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $38 | -60.4% | 1,615 | -86.2% | 0.00% | -50.0% |
Q4 2022 | $96 | -99.8% | 11,669 | -11.5% | 0.01% | +100.0% |
Q3 2022 | $59,000 | +13.5% | 13,190 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $52,000 | -45.3% | 13,190 | -58.1% | 0.00% | -20.0% |
Q1 2022 | $95,000 | +25.0% | 31,490 | -52.4% | 0.01% | +66.7% |
Q4 2021 | $76,000 | -11.6% | 66,090 | +209.0% | 0.00% | -25.0% |
Q3 2021 | $86,000 | +87.0% | 21,390 | +146.1% | 0.00% | +100.0% |
Q2 2021 | $46,000 | +7.0% | 8,690 | +93.5% | 0.00% | 0.0% |
Q1 2021 | $43,000 | +38.7% | 4,490 | -2.4% | 0.00% | +100.0% |
Q4 2020 | $31,000 | +158.3% | 4,600 | -32.4% | 0.00% | – |
Q3 2020 | $12,000 | -42.9% | 6,800 | -21.8% | 0.00% | -100.0% |
Q2 2020 | $21,000 | +90.9% | 8,700 | +89.1% | 0.00% | +100.0% |
Q1 2020 | $11,000 | -56.0% | 4,600 | -42.5% | 0.00% | -50.0% |
Q4 2019 | $25,000 | -39.0% | 8,000 | -3.6% | 0.00% | -33.3% |
Q3 2019 | $41,000 | +412.5% | 8,300 | +492.9% | 0.00% | – |
Q2 2019 | $8,000 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |